Welcome to our dedicated page for GRCK news (Ticker: GRCK), a resource for investors and traders seeking the latest updates and insights on GRCK stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GRCK's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GRCK's position in the market.
Healthy Extracts (OTCQB:HYEX) reported strong Q2 2024 results with net revenue up 54% to a record $908,000. Key highlights include:
- Gross profit increased 71% to $486,000 with margin up to 53.5%
- Third consecutive positive cash flow quarter, generating $80,000
- Net income of $113,500 or $0.04 per share
- Amazon 'Subscribe & Save' customers up 70% year-over-year
- Direct-to-consumer subscription customers up 26% year-over-year
The company anticipates continued growth in 2024 with new product introductions, including WHITNEY JOHNS™ NUTRITION collagen gel packs and BergaMet MYNUS sugar blocker. Healthy Extracts expects strong performance in top-line growth, increased cash flow, profitability, and market share expansion.
Grey Cloak Tech Inc. will officially rebrand as Healthy Extracts Inc. on March 1, 2021, accompanied by a new ticker symbol HYEX. This transition aims to better align the company's corporate structure with its focus on proprietary natural plant-based formulations, particularly in cardiovascular and neuro products. The rebranding reflects an optimistic outlook, as stated by President Duke Pitts, who emphasized the importance of this step for future business growth.
Grey Cloak Tech Inc. (OTC: GRCK), soon to be Healthy Extracts Inc., has filed an application to uplist to the OTCQB Venture Market, aiming to enhance its visibility and accessibility for investors. This move is anticipated to strengthen the company's profile and affirm its commitment to growth in the nutraceutical sector. The OTCQB provides a platform for companies to improve trading liquidity while adhering to strict financial reporting standards. The company's subsidiaries focus on natural plant-based formulations for cardiovascular and neuro health.
Grey Cloak Tech Inc. (OTC: GRCK) has announced a strategic name change to Healthy Extracts Inc., reflecting its focus on proprietary natural plant-based formulations. The company has seen significant revenue growth over the past 18 months while reducing debt and acquiring two nutraceutical subsidiaries. They introduced Clinical IMMUNE™, a new product aimed at enhancing immune defense against respiratory symptoms, marketed as a cost-effective alternative to other immune products available. The trading symbol will also change to a new symbol soon.
Grey Cloak Tech Inc. (OTC: GRCK), soon to be Healthy Extracts Inc., has launched a new customer relationship management (CRM) program through its subsidiary, BergaMet NA. This initiative aims to boost sales and enhance customer engagement by creating a personalized experience. The company offers a range of natural products, including the recent Clinical IMMUNE product, which is designed to improve immune health. BergaMet NA's products are available on various platforms including Amazon, addressing cardiovascular health and metabolic syndrome.
Grey Cloak Tech Inc. (OTC: GRCK), soon to be renamed Healthy Extracts Inc., announces the launch of BergaMet Clinical IMMUNE, a concentrated nutraceutical designed to enhance immune defense. This supplement combines Citrus Bergamot SuperFruit and BetaVia Complete along with nine other ingredients, promising effective immune support with only two pills daily, at a cost of under $40 a month. Clinical trials showed a 70% reduction in upper respiratory symptoms and fewer sick days. The product aims to address health concerns exacerbated by urban pollution and is available for purchase online and through select physicians.
